Insider Transactions Reported by 13 Insiders of Liminatus Pharma, Inc.

Symbol
LIMN, LIMNW on Nasdaq
Location
La Palma, CA

There are no Buy or Sell transactions made by insiders since 15 Jan 2025

Liminatus Pharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Iris Acquisition Holdings LLC 10%+ Owner $45,885,000 30 Apr 2025
Valetudo Therapeutics LLC 10%+ Owner $32,204,299 30 Apr 2025
KH Feelux Co., Ltd 10%+ Owner $20,880,000 30 Apr 2025
Byong C. Yoo Chief Science Officer 30 Apr 2025
Beom K. Choi Chief Technology Officer 30 Apr 2025
Chris Kim Chief Executive Officer, Director, 10%+ Owner 30 Apr 2025
Scott Dam Chief Financial Officer 30 Apr 2025
Eun Sook Lee Director 30 Apr 2025
Ji Yeon Baek Director 30 Apr 2025
Nicholas Fernandez Director 30 Apr 2025
Sang-Jin Lee Head of Research & Development 30 Apr 2025
II Philip Wayne Lemons Director 10 Jul 2025
Richard Baek Director 10 Jul 2025

There are no transactions filed by insiders of Liminatus Pharma, Inc.